University Of Michigan Benefits Office
Web site A - Z
Confidentiality Statement
HRAA Home




Home Benefits Services Job Groups Benefits Plans Life Events Forms FAQ Our Office Contact Us UM Gateway
UM HRAA Benefits Office Plans Prescription Drug Plan

Prescription Drug Plan

Benefits Plans Home
Prescription Drug Plan Home
Drug Updates and New Releases


Questions

Contact Us
HR/Payroll Service Center

 

image

New 2009 Rx drug co-pays announced

By Dave Reid
HR Communications

The University will change the co-pay amounts paid by members of the U-M Prescription Drug Plan next year, the first such adjustment since 2003. The change brings co-pay reductions to those using generic medications, "tier one" drugs in the U-M plan, with a decrease in out-of-pocket expenses from the current $7 co-pay to $5, starting Jan. 1. Those who choose from the two other tiers of brand-name drugs will see co-pays increase to $15 for tier two medications (up from the current $14) and $30 for tier three drugs (up from $24).

"The structure of the plan will be unchanged at three tiers of coverage to continue to support choice, while encouraging the use of generics," says Marty Eichstadt, director of benefits. "Nearly all classes of maintenance medications now include high-quality, FDA-approved generic options."

The University reports more than 67 percent of drugs dispensed under the drug plan are generic medications. Plan Manager Keith Bruhnsen says this rate is greater than average and significantly contributes to overall cost containment as well as reduction of out-of-pocket member expenses.

"The increased use of generic medications and the changes to our co-pay amounts that encourage their use are supported by the U-M Prescription Drug Plan's Pharmacy Advisory Committee and Oversight Committee and the research of the U-M College of Pharmacy," Bruhnsen says.

The U-M Prescription Drug Plan's annual report shows that the increase in generic drug use between 2006 and 2007 alone may have saved more than $2.8 million in additional expense if higher-cost brand-name drugs had otherwise been dispensed. Each 1-percent increase in the U-M rate of generic drug dispensing is reported to bring a savings of nearly $500,000 in reduced medication and co-pay costs.

"It demonstrates the benefit of good health care consumer behavior toward reducing costs," Eichstadt says. "U-M co-pays continue to be lower than peer academic institutions, health systems and the national co-pay averages, so this change maintains our competitive stance and rewards the majority of our plan members who are using generic drugs with a reduction in co-pays."

For more on the U-M Prescription Drug Plan and other benefit programs, go to www.umich.edu/~benefits/.

 

Every effort has been made to ensure the accuracy of the benefits information in this site. However, if any provision on the benefits plans is unclear or ambiguous, the Benefits Office reserves the right to interpret the plan and resolve the problem. If any inconsistency exists between this site and the written plans or contracts, the actual provisions of each benefit plan will govern. The University in its sole discretion may modify, amend, or terminate the benefits provided with respect to any individual receiving benefits, including active employees, retirees, and their dependents. 

©2002 University of Michigan Human Resources and Affirmative Action | Benefits Office | Wolverine Tower - Low Rise G250, 3003 South State Street, Ann Arbor MI 48109-1278 | Fax (734) 763-0363